Immunology of hepatitis B and hepatitis C virus infections
- PMID: 19187866
- DOI: 10.1016/j.bpg.2008.11.015
Immunology of hepatitis B and hepatitis C virus infections
Abstract
Hepatitis B (HBV) and hepatitis C (HCV) viruses are the two major causes of chronic liver inflammation worldwide. Despite distinct virologic features, both viruses are preferentially hepatotropic, not directly cytopathic, and elicit liver diseases that share several aspects of their natural history. HBV and HCV infections also share some important features of the adaptive antiviral immune response. We describe the innate immune response in the early phase following infection, and how these early events may influence the development of the adaptive immune response in these two important viral infections. The mechanisms by which high levels of viral antigens, liver immunological features, the presence of regulatory T cells and impaired dendritic cell functions may maintain the HBV- and HCV-specific immunological failure, characteristic of chronic hepatitis B and C patients, are also evaluated.
Similar articles
-
Immunology of hepatitis B virus and hepatitis C virus infection.Nat Rev Immunol. 2005 Mar;5(3):215-29. doi: 10.1038/nri1573. Nat Rev Immunol. 2005. PMID: 15738952 Review.
-
[The role of the virus specific T-cell response in acute and chronic HBV and HCV infection].Z Gastroenterol. 2004 Jan;42(1):39-46. doi: 10.1055/s-2004-812688. Z Gastroenterol. 2004. PMID: 14997402 Review. German.
-
Hepatitis C pathogenesis: mechanisms of viral clearance and liver injury.Liver Transpl. 2003 Nov;9(11):S35-43. doi: 10.1053/jlts.2003.50253. Liver Transpl. 2003. PMID: 14586893 Review.
-
Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B.Gastroenterology. 2008 Jun;134(7):1938-49, 1949.e1-3. doi: 10.1053/j.gastro.2008.03.037. Epub 2008 Mar 22. Gastroenterology. 2008. PMID: 18455515
-
[Impaired non-viral specific immune function of dendritic cell does not interfere with clearance and cytotoxic T lymphocyte response to HBV or HCV].Zhonghua Gan Zang Bing Za Zhi. 2004 Feb;12(2):67-71. Zhonghua Gan Zang Bing Za Zhi. 2004. PMID: 14980100 Chinese.
Cited by
-
Overcoming HBV immune tolerance to eliminate HBsAg-positive hepatocytes via pre-administration of GM-CSF as a novel adjuvant for a hepatitis B vaccine in HBV transgenic mice.Cell Mol Immunol. 2016 Nov;13(6):850-861. doi: 10.1038/cmi.2015.64. Epub 2015 Jul 13. Cell Mol Immunol. 2016. PMID: 26166767 Free PMC article.
-
The Effect of Chronic Hepatitis B Virus Infection on BDCA3+ Dendritic Cell Frequency and Function.PLoS One. 2016 Aug 16;11(8):e0161235. doi: 10.1371/journal.pone.0161235. eCollection 2016. PLoS One. 2016. PMID: 27529176 Free PMC article.
-
Pathological process of liver sinusoidal endothelial cells in liver diseases.World J Gastroenterol. 2017 Nov 21;23(43):7666-7677. doi: 10.3748/wjg.v23.i43.7666. World J Gastroenterol. 2017. PMID: 29209108 Free PMC article. Review.
-
DNA Vectors Generating Engineered Exosomes Potential CTL Vaccine Candidates Against AIDS, Hepatitis B, and Tumors.Mol Biotechnol. 2018 Nov;60(11):773-782. doi: 10.1007/s12033-018-0114-3. Mol Biotechnol. 2018. PMID: 30167966
-
Nanotoxicity overview: nano-threat to susceptible populations.Int J Mol Sci. 2014 Feb 28;15(3):3671-97. doi: 10.3390/ijms15033671. Int J Mol Sci. 2014. PMID: 24590128 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical